Report in English with a Dutch summary (KCE reports 45A)
Report in English with a Dutch summary (KCE reports 45A)
Report in English with a Dutch summary (KCE reports 45A)
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>KCE</strong> <strong>reports</strong> vol.45 Screen<strong>in</strong>g for Colorectal Cancer: Appendices 143<br />
8 IMPLEMENTATION SCENARIOS AND<br />
BUDGET IMPACT<br />
8.1 SCENARIOS<br />
To estimate the budget impact of mass screen<strong>in</strong>g for colorectal cancer we<br />
analysed two general implementation scenarios. It should be emphasised that<br />
the goal of these analyses is limited to budget impact estimation and that they<br />
should not be considered as a cost-effectiveness analysis of screen<strong>in</strong>g tests.<br />
These cost-effectiveness analyses are described <strong>in</strong> chapter 6.<br />
In a first scenario an <strong>in</strong>dividual from the target group receives an <strong>in</strong>vitation by<br />
mail to participate <strong>in</strong> the screen<strong>in</strong>g program and to visit his GP for delivery of<br />
the test kit. Dur<strong>in</strong>g a first visit the GP identifies the pre-screen<strong>in</strong>g risk of the<br />
<strong>in</strong>dividual. Individuals who are at high risk for colorectal cancer should be<br />
followed up for this risk (surveillance) and are therefore excluded from the<br />
mass screen<strong>in</strong>g program. For average risk <strong>in</strong>dividuals, the GP provides extensive<br />
<strong>in</strong>formation about the aims, consequences and drawbacks of CRC screen<strong>in</strong>g,<br />
and if they agree to participate they are given the FOBT test kit. After<br />
completion of the test the participant receives his result through the GP. If the<br />
test is positive the participant is advised to undergo colonoscopy and referred<br />
for the procedure. This scenario is further called the GP system .<br />
In a second scenario, an <strong>in</strong>dividual from the target group is aga<strong>in</strong> <strong>in</strong>vited by mail<br />
to participate <strong>in</strong> the screen<strong>in</strong>g program, but <strong>in</strong> this scenario the letter conta<strong>in</strong>s<br />
the test kit, together <strong>with</strong> detailed <strong>in</strong>formation about the nature of the<br />
program, consequences, exclusion criteria, and <strong>in</strong>structions for use of the test<br />
kit. The test is performed by the <strong>in</strong>dividual and mailed to the laboratory. The<br />
results are mailed to the participant and the GP. If positive, the participant is<br />
advised to visit his GP, where the participant is counselled and referred for<br />
colonoscopy. This scenario is further called the mail<strong>in</strong>g system .<br />
Both scenarios will be presented for a target group aged 50-74 and a target<br />
group aged 55-74. A dist<strong>in</strong>ction is made between the first round of screen<strong>in</strong>g<br />
and the second and subsequent rounds of screen<strong>in</strong>g. This dist<strong>in</strong>ction is<br />
important because the <strong>in</strong>troduction of a previously non-exist<strong>in</strong>g screen<strong>in</strong>g<br />
program <strong>in</strong>duces a higher detection rate of cancer that will not be reached once<br />
the program is runn<strong>in</strong>g for several years.<br />
The budget impact as well as the cost per CRC detected of both scenarios <strong>in</strong><br />
both age groups is estimated by means of an economic model. The analyses are<br />
performed from a third payer perspective.<br />
8.1.1 Basel<strong>in</strong>e analysis: biennial screen<strong>in</strong>g <strong>with</strong> unrehydrated gFOBT<br />
As most evidence is available <strong>in</strong> literature for a biennial screen<strong>in</strong>g strategy <strong>with</strong><br />
unrehydrated gFOBT, this will be our basel<strong>in</strong>e analysis. Apart from data from<br />
the literature (mostly for cl<strong>in</strong>ical variables), data from national databases (e.g.<br />
for costs of procedures, population size) are used <strong>in</strong> the model. It is assumed<br />
that, at the start of the screen<strong>in</strong>g program, half of the population <strong>in</strong> the target<br />
group is be<strong>in</strong>g offered screen<strong>in</strong>g <strong>in</strong> the first year and the other half <strong>in</strong> the<br />
second year. Therefore, the first screen<strong>in</strong>g round is def<strong>in</strong>ed as the first and<br />
second year of the screen<strong>in</strong>g program, the second round as the third and fourth<br />
year. Results are identical <strong>in</strong> the two years of the same screen<strong>in</strong>g round.